SLRX
Salarius Pharmaceuticals Inc. Common Stock
$0.707+-0.000 (-0.000%)
Echtzeitkurs
Kursdiagramm
Loading Chart...
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$0.707
Hoch
$0.707
Tief
$0.707
Volumen
0.07M
Unternehmensfundamentaldaten
Handelsstatistiken
Ähnliche Nachrichten
GlobeNewswire
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
CAMBRIDGE, Mass. and HOUSTON, March 26, 2025 (GLOBE NEWSWIRE) -- Decoy Therapeutics Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide-conjugate
Mehr anzeigen
GlobeNewswire
Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating respiratory viruses and
Mehr anzeigen
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.